Weโre pleased to share the latest developments across our subsidiaries from this morningโs LSE update:
๐น ๐๐ฎ๐ฏ-๐๐ฟ๐ผ๐๐ป ๐๐ฒ๐ฎ๐๐ต๐ฒ๐ฟ (๐๐๐): LGL continues to lead the way as the only producer of fully lab-grown, scaffold-free leather, having supplied samples to a major luxury goods company and preparing for a luxury automotive brand trial. Three of the worldโs top luxury brands are now working with us on development programmes.
๐น ๐ฏ๐ ๐๐ถ๐ผ-๐ง๐ถ๐๐๐๐ฒ๐: Following a successful soft launch, ๐๐๐๐ผ๐๐ผ๐ผ๐๐โข has received strong interest from multiple biopharma companies, while ๐๐ถ๐๐-๐ ๐ถ๐
โข is advancing in testing stages with repeat orders and tech transfer projects.
๐น ๐๐๐น๐๐ถ๐๐ฎ๐๐ฒ๐ฑ ๐ ๐ฒ๐ฎ๐ ๐ง๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐ถ๐ฒ๐ (๐๐ ๐ง): The Company has decided not to proceed with the proposed joint venture with CellulaRevolution Ltd (CellRev). Instead, it will explore alternative pathways to establish cultivated meat products in collaboration with major food processors, producers, and retailers in the UK and Europe.
๐น ๐๐ฒ๐ฟ๐ฎ๐๐ผ ๐๐๐ฑ: Preparations for veterinary trials of ๐๐ถ๐ค๐ ๐๐ผ๐ฟ๐ป๐ฒ๐ฎ are underway with Dr. Maria Vanoreโs team at Universitรฉ de Montrรฉal, targeting Q1 2025. Positive feedback from international ophthalmologists also supports upcoming human trials in 2026.
๐น ๐๐ผ๐ฟ๐ฝ๐ผ๐ฟ๐ฎ๐๐ฒ ๐จ๐ฝ๐ฑ๐ฎ๐๐ฒ: We have allotted shares to investment podcast firm PR Roast at a premium, enhancing our investor outreach.
These strategic moves underscore our dedication to pioneering sustainable, cell-based technologies across diverse industries.
